Salle de presse

Nos dernières mises à jour sur la nutrition, la santé et la beauté

     Entreprise  & Nouvelles financières
  • dsm-firmenich Running Team makes global debut to pioneer a new era of elite running

    5 January 2026

    dsm-firmenich Running Team makes global debut to pioneer a new era of elite running

  • dsm-firmenich unveils the Cloud Dancer fragrance collection inspired by PANTONE® Color of the Year 2026

    4 December 2025

    dsm-firmenich unveils the Cloud Dancer fragrance collection inspired by PANTONE® Color of the Year 2026

  • Meet the VIPs who changed the world of taste and fragrances

    3 December 2025

    Meet the VIPs who changed the world of taste and fragrances

  • dsm-firmenich completes €1.08 billion share repurchase program

    2 December 2025

    dsm-firmenich completes €1.08 billion share repurchase program

  • Weekly progress on share repurchase program to cover share plans and reduce capital

    25 November 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

  • dsm-firmenich launches The Art of Progress Prize

    25 November 2025

    dsm-firmenich launches The Art of Progress Prize

  • Weekly progress on share repurchase program to cover share plans and reduce capital

    18 November 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

  • Weekly progress on share repurchase program to cover share plans and reduce capital

    11 November 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

  • Weekly progress on share repurchase program to cover share plans and reduce capital

    4 November 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

  • Weekly progress on share repurchase program to cover share plans and reduce capital

    28 October 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

  • Weekly progress on share repurchase program to cover share plans and reduce capital

    21 October 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

  • Weekly progress on share repurchase program to cover share plans and reduce capital

    14 October 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

  • How your first 1000 days shape the rest of your life

    8 October 2025

    How your first 1000 days shape the rest of your life

  • Weekly progress on share repurchase program to cover share plans and reduce capital

    7 October 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

  • dsm-firmenich opens global food innovation center in Delft, the Netherlands to accelerate diet transformation

    2 October 2025

    dsm-firmenich opens global food innovation center in Delft, the Netherlands to accelerate diet transformation

  • Weekly progress on share repurchase program to cover share plans and reduce capital

    30 September 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

  • Weekly progress on share repurchase program to cover share plans and reduce capital

    23 September 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

  • Weekly progress on share repurchase program to cover share plans and reduce capital

    16 September 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

  • Weekly progress on share repurchase program to cover share plans and reduce capital

    9 September 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

  • dsm-firmenich achieves target of 100% purchased renewable electricity

    3 September 2025

    dsm-firmenich achieves target of 100% purchased renewable electricity

  • dsm-firmenich unveils emotiOn™ social connection

    2 September 2025

    dsm-firmenich unveils emotiOn™ social connection

  • Weekly progress on share repurchase program to cover share plans and reduce capital

    2 September 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

  • dsm-firmenich strengthens its Executive Committee for future growth as a consumer-focused company

    1 September 2025

    dsm-firmenich strengthens its Executive Committee for future growth as a consumer-focused company

  • Weekly progress on share repurchase program to cover share plans and reduce capital

    26 August 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

  • Weekly progress on share repurchase program to cover share plans and reduce capital

    19 August 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

  • Weekly progress on share repurchase program to cover share plans and reduce capital

    12 August 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

  • Weekly progress on share repurchase program to cover share plans and reduce capital

    5 August 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

  • Weekly progress on share repurchase program to cover share plans and reduce capital

    29 July 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

  • Weekly progress on share repurchase program to cover share plans and reduce capital

    22 July 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

  • Weekly progress on share repurchase program to cover share plans and reduce capital

    15 July 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

  • Weekly progress on share repurchase program to cover share plans and reduce capital

    8 July 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

  • dsm-firmenich announces Jonathan Simon as next President of Fine Fragrance

    1 July 2025

    dsm-firmenich announces Jonathan Simon as next President of Fine Fragrance

  • Weekly progress on share repurchase program to cover share plans and reduce capital

    1 July 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

  • dsm-firmenich announces redemption of €750 million hybrid bond

    1 July 2025

    dsm-firmenich announces redemption of €750 million hybrid bond

  • dsm-firmenich announces increase in share repurchase program to reduce capital to €1 billion

    27 June 2025

    dsm-firmenich announces increase in share repurchase program to reduce capital to €1 billion

  • dsm-firmenich and the United Nations World Food Programme expand partnership through 2027

    25 June 2025

    dsm-firmenich and the United Nations World Food Programme expand partnership through 2027

  • Weekly progress on share repurchase program to cover share plans and reduce capital

    24 June 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

  • Weekly progress on share repurchase program to cover share plans and reduce capital

    17 June 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

  • dsm-firmenich and Honeywell have reached a settlement to resolve their disputes relating to dsm-firmenich’s US Patent No. 10,280,532 and Honeywell’s Spectra® MG BIO Blue fiber.

    13 June 2025

    dsm-firmenich and Honeywell have reached a settlement to resolve their disputes relating to dsm-firmenich’s US Patent No. 10,280,532 and Honeywell’s Spectra® MG BIO Blue fiber.

  • Weekly progress on share repurchase program to cover share plans and reduce capital

    10 June 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

  • dsm-firmenich breaks ground on new state-of-the-art production facility for the development of flavors and functional blends in Parma, Italy

    4 June 2025

    dsm-firmenich breaks ground on new state-of-the-art production facility for the development of flavors and functional blends in Parma, Italy

  • Weekly progress on share repurchase program to cover share plans and reduce capital

    3 June 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

  • dsm-firmenich completes sale of its stake in Feed Enzymes Alliance to Novonesis for €1.5 billion

    2 June 2025

    dsm-firmenich completes sale of its stake in Feed Enzymes Alliance to Novonesis for €1.5 billion

  • Weekly progress on share repurchase program to cover share plans and reduce capital

    27 May 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

  • On the rise: dsm-firmenich opens state-of-the-art Princeton Baking Innovation Center in Princeton, NJ

    20 May 2025

    On the rise: dsm-firmenich opens state-of-the-art Princeton Baking Innovation Center in Princeton, NJ

  • Weekly progress on share repurchase program to cover share plans and reduce capital

    20 May 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

  • Weekly progress on share repurchase program to cover share plans and reduce capital

    13 May 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

  • dsm-firmenich shareholders approve all resolutions at Annual General Meeting 2025

    6 May 2025

    dsm-firmenich shareholders approve all resolutions at Annual General Meeting 2025

  • Weekly progress on share repurchase program to cover share plans and reduce capital

    6 May 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

  • Weekly progress on share repurchase program to cover share plans and reduce capital

    29 April 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

  • Weekly progress on share repurchase program to cover share plans and reduce capital

    22 April 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

  • Weekly progress on share repurchase program to cover share plans and reduce capital

    15 April 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

  • Weekly progress on share repurchase program to cover share plans and reduce capital

    8 April 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

  • Laetitia Pictet appointed Chief Legal, Risk and Compliance Officer of dsm-firmenich

    8 April 2025

    Laetitia Pictet appointed Chief Legal, Risk and Compliance Officer of dsm-firmenich

  • dsm-firmenich completes shareholding increase in Andre Pectin to 90.5%

    3 April 2025

    dsm-firmenich completes shareholding increase in Andre Pectin to 90.5%

  • dsm-firmenich announces share repurchase program to cover share plans and reduce capital

    1 April 2025

    dsm-firmenich announces share repurchase program to cover share plans and reduce capital

  • dsm-firmenich showcases integrated approach to sustainability and business performance at Sustainability Investor Day

    25 March 2025

    dsm-firmenich showcases integrated approach to sustainability and business performance at Sustainability Investor Day

  • dsm-firmenich launches Maxiren®EVO: A revolutionary coagulant enzyme for enhanced cheese texture, taste, yield, and functionality

    20 March 2025

    dsm-firmenich launches Maxiren®EVO: A revolutionary coagulant enzyme for enhanced cheese texture, taste, yield, and functionality

  • dsm-firmenich scents the Swiss and Dutch Pavilions at Expo 2025 in Osaka

    17 March 2025

    dsm-firmenich scents the Swiss and Dutch Pavilions at Expo 2025 in Osaka

  • dsm-firmenich publishes 2024 Integrated Annual Report

    28 February 2025

    dsm-firmenich publishes 2024 Integrated Annual Report

  • dsm-firmenich recognized as a "Top 100 Global Innovator" in LexisNexis 2025 Innovation Momentum Report

    21 February 2025

    dsm-firmenich recognized as a "Top 100 Global Innovator" in LexisNexis 2025 Innovation Momentum Report

  • dsm-firmenich issues €750 million long-term bond

    19 February 2025

    dsm-firmenich issues €750 million long-term bond

  • dsm-firmenich to sell stake in Feed Enzymes Alliance to its partner Novonesis for €1.5 billion

    11 February 2025

    dsm-firmenich to sell stake in Feed Enzymes Alliance to its partner Novonesis for €1.5 billion

  • Why healthy aging is more than just living longer

    7 February 2025

    Why healthy aging is more than just living longer

  • On the ground in Kenya: teaming up with WFP against malnutrition

    16 December 2024

    On the ground in Kenya: teaming up with WFP against malnutrition

  • Bringing color to life: our fragrance and flavor inspired by PANTONE® color of the year

    6 December 2024

    Bringing color to life: our fragrance and flavor inspired by PANTONE® color of the year

  • dsm-firmenich Unveils Mocha Mousse, a New Sensual Scent Inspired by the PANTONE® Color of the Year 2025

    6 December 2024

    dsm-firmenich Unveils Mocha Mousse, a New Sensual Scent Inspired by the PANTONE® Color of the Year 2025

  • DSM-Firmenich AG sold all of its stake in Robertet S.A.

    21 November 2024

    DSM-Firmenich AG sold all of its stake in Robertet S.A.

  • DSM-Firmenich AG sold the majority of its stake in Robertet S.A.

    15 November 2024

    DSM-Firmenich AG sold the majority of its stake in Robertet S.A.

  • DSM-Firmenich AG to sell part of its stake in Robertet S.A.

    14 November 2024

    DSM-Firmenich AG to sell part of its stake in Robertet S.A.

  • dsm-firmenich presents ‘Imagine: The Future of Fragrances in the Middle East’ at Beauty World 2024

    30 October 2024

    dsm-firmenich presents ‘Imagine: The Future of Fragrances in the Middle East’ at Beauty World 2024

  • dsm-firmenich receives validation from the Science Based Targets initiative for its 2045 net-zero targets

    24 October 2024

    dsm-firmenich receives validation from the Science Based Targets initiative for its 2045 net-zero targets

  • dsm-firmenich participates in Beauty World Dubai 2024

    21 October 2024

    dsm-firmenich participates in Beauty World Dubai 2024

  • dsm-firmenich completes the sale of yeast extract business to Lesaffre

    2 October 2024

    dsm-firmenich completes the sale of yeast extract business to Lesaffre

  • dsm-firmenich completes the sale of its MEG-3® fish oil business to KD Pharma Group SA

    1 October 2024

    dsm-firmenich completes the sale of its MEG-3® fish oil business to KD Pharma Group SA

  • dsm-firmenich Welcomes Nicole Mancini as Fine Fragrance Principal Perfumer

    29 August 2024

    dsm-firmenich Welcomes Nicole Mancini as Fine Fragrance Principal Perfumer

  • dsm-firmenich concludes new €1.8 billion Revolving Credit Facility

    8 August 2024

    dsm-firmenich concludes new €1.8 billion Revolving Credit Facility

  • dsm-firmenich to sell MEG-3® fish oil business to KD Pharma Group

    18 July 2024

    dsm-firmenich to sell MEG-3® fish oil business to KD Pharma Group

  • dsm-firmenich issues €800 million long-term bond

    26 June 2024

    dsm-firmenich issues €800 million long-term bond

  • dsm-firmenich to launch groundbreaking new sports nutrition solutions in collaboration with Team dsm-firmenich PostNL

    26 June 2024

    dsm-firmenich to launch groundbreaking new sports nutrition solutions in collaboration with Team dsm-firmenich PostNL

  • dsm-firmenich gains momentum showcasing the best in ingredients innovation and fragrance experience

    18 June 2024

    dsm-firmenich gains momentum showcasing the best in ingredients innovation and fragrance experience

  • DSM shareholders can voluntarily transfer their shares to dsm-firmenich before July 2, 2024, 17:45 hours CEST

    14 June 2024

    DSM shareholders can voluntarily transfer their shares to dsm-firmenich before July 2, 2024, 17:45 hours CEST

  • dsm-firmenich announces sale of yeast extract business to Lesaffre

    12 June 2024

    dsm-firmenich announces sale of yeast extract business to Lesaffre

  • dsm-firmenich takes strategic actions to strengthen its position as a leading creation and innovation partner in Nutrition, Health and Beauty

    3 June 2024

    dsm-firmenich takes strategic actions to strengthen its position as a leading creation and innovation partner in Nutrition, Health and Beauty

  • dsm-firmenich implements a cross guarantee agreement to mitigate structural subordination and establish a pari-passu debt platform

    31 May 2024

    dsm-firmenich implements a cross guarantee agreement to mitigate structural subordination and establish a pari-passu debt platform

  • dsm-firmenich dual head office Maastricht inaugurated by Queen Maxima of the Netherlands

    30 May 2024

    dsm-firmenich dual head office Maastricht inaugurated by Queen Maxima of the Netherlands

  • Methane-reducing feed ingredient Bovaer® ready for US market launch

    29 May 2024

    Methane-reducing feed ingredient Bovaer® ready for US market launch

  • dsm-firmenich commits to a strategic partnership with The Colors

    29 May 2024

    dsm-firmenich commits to a strategic partnership with The Colors

  • Celebrating diversity and disability inclusion in the fragrance industry

    21 May 2024

    Celebrating diversity and disability inclusion in the fragrance industry

  • dsm-firmenich presents Mind Nose + Matter™ 2024 - “Momentum”

    17 May 2024

    dsm-firmenich presents Mind Nose + Matter™ 2024 - “Momentum”

  • dsm-firmenich and Lallemand Health Solutions unite to launch synergistic synbiotic solutions

    8 May 2024

    dsm-firmenich and Lallemand Health Solutions unite to launch synergistic synbiotic solutions

  • dsm-firmenich shareholders approve all resolutions at Annual General Meeting 2024

    7 May 2024

    dsm-firmenich shareholders approve all resolutions at Annual General Meeting 2024

  • Share repurchase program to cover share plans completed

    7 May 2024

    Share repurchase program to cover share plans completed

  • dsm-firmenich's progress on share repurchase program to cover share plans

    30 April 2024

    dsm-firmenich's progress on share repurchase program to cover share plans

  • Unlocking the value of sustainability in animal protein value chains with Sustell™

    23 April 2024

    Unlocking the value of sustainability in animal protein value chains with Sustell™

  • dsm-firmenich completes on-market repurchase of 500,000 shares to cover share plans

    16 April 2024

    dsm-firmenich completes on-market repurchase of 500,000 shares to cover share plans

  • dsm-firmenich Partners with ExoLab Italia to Pioneer Plant-Derived Exosome Technology in Personal Care Market

    16 April 2024

    dsm-firmenich Partners with ExoLab Italia to Pioneer Plant-Derived Exosome Technology in Personal Care Market

  • dsm-firmenich announces repurchase of 1.5m shares to cover share plans

    8 April 2024

    dsm-firmenich announces repurchase of 1.5m shares to cover share plans

  • dsm-firmenich donates DSM Art Collection to the municipality of Heerlen

    27 March 2024

    dsm-firmenich donates DSM Art Collection to the municipality of Heerlen

  • dsm-firmenich partners with Interstellar Lab, leading the way in naturals innovation for Perfumery & Beauty

    19 March 2024

    dsm-firmenich partners with Interstellar Lab, leading the way in naturals innovation for Perfumery & Beauty

  • dsm-firmenich opens state-of-the-art facility in Plainsboro NJ, to scale up innovations in F&B

    18 March 2024

    dsm-firmenich opens state-of-the-art facility in Plainsboro NJ, to scale up innovations in F&B

  • Increasing production capacity for perfumery ingredients in Europe

    14 March 2024

    Increasing production capacity for perfumery ingredients in Europe

  • dsm-firmenich completes the divestiture of its Jiangshan Vitamin C plant in China

    8 March 2024

    dsm-firmenich completes the divestiture of its Jiangshan Vitamin C plant in China

  • dsm-firmenich publishes 2023 Integrated Annual Report

    29 February 2024

    dsm-firmenich publishes 2023 Integrated Annual Report

  • dsm-firmenich to separate out Animal Nutrition & Health business from the Group

    14 February 2024

    dsm-firmenich to separate out Animal Nutrition & Health business from the Group

  • dsm-firmenich completes voluntary cash offer for DSM shares

    12 February 2024

    dsm-firmenich completes voluntary cash offer for DSM shares

  • Avansya, a 50/50 joint venture between dsm-firmenich and Cargill received positive safety opinions from European Food Safety Authority and UK Food Standards Agency on it’s product EverSweet® stevia sweetener

    24 January 2024

    Avansya, a 50/50 joint venture between dsm-firmenich and Cargill received positive safety opinions from European Food Safety Authority and UK Food Standards Agency on it’s product EverSweet® stevia sweetener

  • dsm-firmenich appoints five new Principal Perfumers

    8 January 2024

    dsm-firmenich appoints five new Principal Perfumers

  • dsm-firmenich makes voluntary cash offer for DSM shares

    8 January 2024

    dsm-firmenich makes voluntary cash offer for DSM shares

  • dsm-firmenich reveals fragrance and flavor inspired by PANTONE® Color of the Year

    8 December 2023

    dsm-firmenich reveals fragrance and flavor inspired by PANTONE® Color of the Year

  • dsm-firmenich inaugurates Kaiseraugst Headquarters and Science & Research Hub

    6 December 2023

    dsm-firmenich inaugurates Kaiseraugst Headquarters and Science & Research Hub

  • dsm-firmenich breaks ground of new Taste, Texture and Health headquarters and application facility in the Netherlands

    1 November 2023

    dsm-firmenich breaks ground of new Taste, Texture and Health headquarters and application facility in the Netherlands

  • dsm-firmenich increases the production capacity of its iconic perfume ingredient Habanolide® with a brand-new facility in Europe

    26 October 2023

    dsm-firmenich increases the production capacity of its iconic perfume ingredient Habanolide® with a brand-new facility in Europe

  • Bringing progress to life for aquatic food systems

    16 October 2023

    Bringing progress to life for aquatic food systems

  • dsm-firmenich achieves regulatory clearance in China for two HMO ingredients for early life nutrition

    10 October 2023

    dsm-firmenich achieves regulatory clearance in China for two HMO ingredients for early life nutrition

  • dsm-firmenich provides additional pro forma financial information for 2022 and 2023

    4 October 2023

    dsm-firmenich provides additional pro forma financial information for 2022 and 2023

  • Trials confirm efficacy of a methane-reducing feed supplement for ruminants in achieving reductions in methane emissions by dairy cows

    4 September 2023

    Trials confirm efficacy of a methane-reducing feed supplement for ruminants in achieving reductions in methane emissions by dairy cows

  • Exploring the Future of Sustainable Food with dsm-firmenich at the Lowlands Festival in the Netherlands

    18 August 2023

    Exploring the Future of Sustainable Food with dsm-firmenich at the Lowlands Festival in the Netherlands

  • dsm-firmenich completes €1.08 billion share repurchase program

    2 December 2025

    dsm-firmenich completes €1.08 billion share repurchase program

  • Weekly progress on share repurchase program to cover share plans and reduce capital

    25 November 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

  • Weekly progress on share repurchase program to cover share plans and reduce capital

    18 November 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

  • Weekly progress on share repurchase program to cover share plans and reduce capital

    11 November 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

  • Weekly progress on share repurchase program to cover share plans and reduce capital

    4 November 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

  • Weekly progress on share repurchase program to cover share plans and reduce capital

    28 October 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

  • Weekly progress on share repurchase program to cover share plans and reduce capital

    21 October 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

  • Weekly progress on share repurchase program to cover share plans and reduce capital

    14 October 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

  • Weekly progress on share repurchase program to cover share plans and reduce capital

    7 October 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

  • Weekly progress on share repurchase program to cover share plans and reduce capital

    30 September 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

  • Weekly progress on share repurchase program to cover share plans and reduce capital

    23 September 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

  • Weekly progress on share repurchase program to cover share plans and reduce capital

    16 September 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

  • Weekly progress on share repurchase program to cover share plans and reduce capital

    9 September 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

  • dsm-firmenich achieves target of 100% purchased renewable electricity

    3 September 2025

    dsm-firmenich achieves target of 100% purchased renewable electricity

  • Weekly progress on share repurchase program to cover share plans and reduce capital

    2 September 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

  • dsm-firmenich strengthens its Executive Committee for future growth as a consumer-focused company

    1 September 2025

    dsm-firmenich strengthens its Executive Committee for future growth as a consumer-focused company

  • Weekly progress on share repurchase program to cover share plans and reduce capital

    26 August 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

  • Weekly progress on share repurchase program to cover share plans and reduce capital

    19 August 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

  • Weekly progress on share repurchase program to cover share plans and reduce capital

    12 August 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

  • Weekly progress on share repurchase program to cover share plans and reduce capital

    5 August 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

  • Weekly progress on share repurchase program to cover share plans and reduce capital

    29 July 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

  • Weekly progress on share repurchase program to cover share plans and reduce capital

    22 July 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

  • Weekly progress on share repurchase program to cover share plans and reduce capital

    15 July 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

  • Weekly progress on share repurchase program to cover share plans and reduce capital

    8 July 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

  • Weekly progress on share repurchase program to cover share plans and reduce capital

    1 July 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

  • dsm-firmenich announces redemption of €750 million hybrid bond

    1 July 2025

    dsm-firmenich announces redemption of €750 million hybrid bond

  • dsm-firmenich announces increase in share repurchase program to reduce capital to €1 billion

    27 June 2025

    dsm-firmenich announces increase in share repurchase program to reduce capital to €1 billion

  • Weekly progress on share repurchase program to cover share plans and reduce capital

    24 June 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

  • Weekly progress on share repurchase program to cover share plans and reduce capital

    17 June 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

  • Weekly progress on share repurchase program to cover share plans and reduce capital

    10 June 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

  • Weekly progress on share repurchase program to cover share plans and reduce capital

    3 June 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

  • dsm-firmenich completes sale of its stake in Feed Enzymes Alliance to Novonesis for €1.5 billion

    2 June 2025

    dsm-firmenich completes sale of its stake in Feed Enzymes Alliance to Novonesis for €1.5 billion

  • Weekly progress on share repurchase program to cover share plans and reduce capital

    27 May 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

  • Weekly progress on share repurchase program to cover share plans and reduce capital

    20 May 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

  • Weekly progress on share repurchase program to cover share plans and reduce capital

    13 May 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

  • dsm-firmenich shareholders approve all resolutions at Annual General Meeting 2025

    6 May 2025

    dsm-firmenich shareholders approve all resolutions at Annual General Meeting 2025

  • Weekly progress on share repurchase program to cover share plans and reduce capital

    6 May 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

  • Weekly progress on share repurchase program to cover share plans and reduce capital

    29 April 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

  • Weekly progress on share repurchase program to cover share plans and reduce capital

    22 April 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

  • Weekly progress on share repurchase program to cover share plans and reduce capital

    15 April 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

  • Weekly progress on share repurchase program to cover share plans and reduce capital

    8 April 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

  • Laetitia Pictet appointed Chief Legal, Risk and Compliance Officer of dsm-firmenich

    8 April 2025

    Laetitia Pictet appointed Chief Legal, Risk and Compliance Officer of dsm-firmenich

  • dsm-firmenich completes shareholding increase in Andre Pectin to 90.5%

    3 April 2025

    dsm-firmenich completes shareholding increase in Andre Pectin to 90.5%

  • dsm-firmenich announces share repurchase program to cover share plans and reduce capital

    1 April 2025

    dsm-firmenich announces share repurchase program to cover share plans and reduce capital

  • dsm-firmenich showcases integrated approach to sustainability and business performance at Sustainability Investor Day

    25 March 2025

    dsm-firmenich showcases integrated approach to sustainability and business performance at Sustainability Investor Day

  • dsm-firmenich publishes 2024 Integrated Annual Report

    28 February 2025

    dsm-firmenich publishes 2024 Integrated Annual Report

  • dsm-firmenich issues €750 million long-term bond

    19 February 2025

    dsm-firmenich issues €750 million long-term bond

  • dsm-firmenich to sell stake in Feed Enzymes Alliance to its partner Novonesis for €1.5 billion

    11 February 2025

    dsm-firmenich to sell stake in Feed Enzymes Alliance to its partner Novonesis for €1.5 billion

  • DSM-Firmenich AG sold all of its stake in Robertet S.A.

    21 November 2024

    DSM-Firmenich AG sold all of its stake in Robertet S.A.

  • DSM-Firmenich AG sold the majority of its stake in Robertet S.A.

    15 November 2024

    DSM-Firmenich AG sold the majority of its stake in Robertet S.A.

  • DSM-Firmenich AG to sell part of its stake in Robertet S.A.

    14 November 2024

    DSM-Firmenich AG to sell part of its stake in Robertet S.A.

  • dsm-firmenich receives validation from the Science Based Targets initiative for its 2045 net-zero targets

    24 October 2024

    dsm-firmenich receives validation from the Science Based Targets initiative for its 2045 net-zero targets

  • dsm-firmenich completes the sale of yeast extract business to Lesaffre

    2 October 2024

    dsm-firmenich completes the sale of yeast extract business to Lesaffre

  • dsm-firmenich completes the sale of its MEG-3® fish oil business to KD Pharma Group SA

    1 October 2024

    dsm-firmenich completes the sale of its MEG-3® fish oil business to KD Pharma Group SA

  • dsm-firmenich concludes new €1.8 billion Revolving Credit Facility

    8 August 2024

    dsm-firmenich concludes new €1.8 billion Revolving Credit Facility

  • dsm-firmenich to sell MEG-3® fish oil business to KD Pharma Group

    18 July 2024

    dsm-firmenich to sell MEG-3® fish oil business to KD Pharma Group

  • dsm-firmenich issues €800 million long-term bond

    26 June 2024

    dsm-firmenich issues €800 million long-term bond

  • DSM shareholders can voluntarily transfer their shares to dsm-firmenich before July 2, 2024, 17:45 hours CEST

    14 June 2024

    DSM shareholders can voluntarily transfer their shares to dsm-firmenich before July 2, 2024, 17:45 hours CEST

  • dsm-firmenich announces sale of yeast extract business to Lesaffre

    12 June 2024

    dsm-firmenich announces sale of yeast extract business to Lesaffre

  • dsm-firmenich takes strategic actions to strengthen its position as a leading creation and innovation partner in Nutrition, Health and Beauty

    3 June 2024

    dsm-firmenich takes strategic actions to strengthen its position as a leading creation and innovation partner in Nutrition, Health and Beauty

  • dsm-firmenich implements a cross guarantee agreement to mitigate structural subordination and establish a pari-passu debt platform

    31 May 2024

    dsm-firmenich implements a cross guarantee agreement to mitigate structural subordination and establish a pari-passu debt platform

  • Methane-reducing feed ingredient Bovaer® ready for US market launch

    29 May 2024

    Methane-reducing feed ingredient Bovaer® ready for US market launch

  • dsm-firmenich shareholders approve all resolutions at Annual General Meeting 2024

    7 May 2024

    dsm-firmenich shareholders approve all resolutions at Annual General Meeting 2024

  • Share repurchase program to cover share plans completed

    7 May 2024

    Share repurchase program to cover share plans completed

  • dsm-firmenich's progress on share repurchase program to cover share plans

    30 April 2024

    dsm-firmenich's progress on share repurchase program to cover share plans

  • dsm-firmenich completes on-market repurchase of 500,000 shares to cover share plans

    16 April 2024

    dsm-firmenich completes on-market repurchase of 500,000 shares to cover share plans

  • dsm-firmenich announces repurchase of 1.5m shares to cover share plans

    8 April 2024

    dsm-firmenich announces repurchase of 1.5m shares to cover share plans

  • dsm-firmenich completes the divestiture of its Jiangshan Vitamin C plant in China

    8 March 2024

    dsm-firmenich completes the divestiture of its Jiangshan Vitamin C plant in China

  • dsm-firmenich publishes 2023 Integrated Annual Report

    29 February 2024

    dsm-firmenich publishes 2023 Integrated Annual Report

  • dsm-firmenich to separate out Animal Nutrition & Health business from the Group

    14 February 2024

    dsm-firmenich to separate out Animal Nutrition & Health business from the Group

  • dsm-firmenich completes voluntary cash offer for DSM shares

    12 February 2024

    dsm-firmenich completes voluntary cash offer for DSM shares

  • dsm-firmenich makes voluntary cash offer for DSM shares

    8 January 2024

    dsm-firmenich makes voluntary cash offer for DSM shares

  • dsm-firmenich achieves regulatory clearance in China for two HMO ingredients for early life nutrition

    10 October 2023

    dsm-firmenich achieves regulatory clearance in China for two HMO ingredients for early life nutrition

  • dsm-firmenich provides additional pro forma financial information for 2022 and 2023

    4 October 2023

    dsm-firmenich provides additional pro forma financial information for 2022 and 2023

  • dsm-firmenich completes acquisition of postbiotics pioneer Adare Biome

    3 July 2023

    dsm-firmenich completes acquisition of postbiotics pioneer Adare Biome

  • dsm-firmenich announces results of extraordinary general meeting of shareholders

    29 June 2023

    dsm-firmenich announces results of extraordinary general meeting of shareholders

  • Trading update and acceleration of strategic actions

    28 June 2023

    Trading update and acceleration of strategic actions

  • Emmanuel Butstraen appointed as President of Perfumery & Beauty at dsm-firmenich

    22 May 2023

    Emmanuel Butstraen appointed as President of Perfumery & Beauty at dsm-firmenich

  • dsm-firmenich names Katharina Stenholm as Chief Sustainability Officer

    17 May 2023

    dsm-firmenich names Katharina Stenholm as Chief Sustainability Officer

  • dsm-firmenich launches as innovators in nutrition, health, and beauty

    9 May 2023

    dsm-firmenich launches as innovators in nutrition, health, and beauty

  • dsm-firmenich announces evolution of CEO structure per 1 September, following completion of the merger

    4 May 2023

    dsm-firmenich announces evolution of CEO structure per 1 September, following completion of the merger

  • Final results of the exchange offer: 96.1% of DSM ordinary shares tendered

    1 May 2023

    Final results of the exchange offer: 96.1% of DSM ordinary shares tendered

  • dsm-firmenich first day of trading on Euronext Amsterdam

    18 April 2023

    dsm-firmenich first day of trading on Euronext Amsterdam

  • Meet the VIPs who changed the world of taste and fragrances

    3 December 2025

    Meet the VIPs who changed the world of taste and fragrances

  • How your first 1000 days shape the rest of your life

    8 October 2025

    How your first 1000 days shape the rest of your life

  • Why healthy aging is more than just living longer

    7 February 2025

    Why healthy aging is more than just living longer

  • On the ground in Kenya: teaming up with WFP against malnutrition

    16 December 2024

    On the ground in Kenya: teaming up with WFP against malnutrition

  • Bringing color to life: our fragrance and flavor inspired by PANTONE® color of the year

    6 December 2024

    Bringing color to life: our fragrance and flavor inspired by PANTONE® color of the year

  • Celebrating diversity and disability inclusion in the fragrance industry

    21 May 2024

    Celebrating diversity and disability inclusion in the fragrance industry

  • Unlocking the value of sustainability in animal protein value chains with Sustell™

    23 April 2024

    Unlocking the value of sustainability in animal protein value chains with Sustell™

  • dsm-firmenich donates DSM Art Collection to the municipality of Heerlen

    27 March 2024

    dsm-firmenich donates DSM Art Collection to the municipality of Heerlen

  • dsm-firmenich partners with Interstellar Lab, leading the way in naturals innovation for Perfumery & Beauty

    19 March 2024

    dsm-firmenich partners with Interstellar Lab, leading the way in naturals innovation for Perfumery & Beauty

  • dsm-firmenich opens state-of-the-art facility in Plainsboro NJ, to scale up innovations in F&B

    18 March 2024

    dsm-firmenich opens state-of-the-art facility in Plainsboro NJ, to scale up innovations in F&B

  • Increasing production capacity for perfumery ingredients in Europe

    14 March 2024

    Increasing production capacity for perfumery ingredients in Europe

  • Avansya, a 50/50 joint venture between dsm-firmenich and Cargill received positive safety opinions from European Food Safety Authority and UK Food Standards Agency on it’s product EverSweet® stevia sweetener

    24 January 2024

    Avansya, a 50/50 joint venture between dsm-firmenich and Cargill received positive safety opinions from European Food Safety Authority and UK Food Standards Agency on it’s product EverSweet® stevia sweetener

  • dsm-firmenich appoints five new Principal Perfumers

    8 January 2024

    dsm-firmenich appoints five new Principal Perfumers

  • dsm-firmenich reveals fragrance and flavor inspired by PANTONE® Color of the Year

    8 December 2023

    dsm-firmenich reveals fragrance and flavor inspired by PANTONE® Color of the Year

  • dsm-firmenich inaugurates Kaiseraugst Headquarters and Science & Research Hub

    6 December 2023

    dsm-firmenich inaugurates Kaiseraugst Headquarters and Science & Research Hub

  • dsm-firmenich breaks ground of new Taste, Texture and Health headquarters and application facility in the Netherlands

    1 November 2023

    dsm-firmenich breaks ground of new Taste, Texture and Health headquarters and application facility in the Netherlands

  • dsm-firmenich increases the production capacity of its iconic perfume ingredient Habanolide® with a brand-new facility in Europe

    26 October 2023

    dsm-firmenich increases the production capacity of its iconic perfume ingredient Habanolide® with a brand-new facility in Europe

  • Bringing progress to life for aquatic food systems

    16 October 2023

    Bringing progress to life for aquatic food systems

  • Trials confirm efficacy of a methane-reducing feed supplement for ruminants in achieving reductions in methane emissions by dairy cows

    4 September 2023

    Trials confirm efficacy of a methane-reducing feed supplement for ruminants in achieving reductions in methane emissions by dairy cows

  • Exploring the Future of Sustainable Food with dsm-firmenich at the Lowlands Festival in the Netherlands

    18 August 2023

    Exploring the Future of Sustainable Food with dsm-firmenich at the Lowlands Festival in the Netherlands

  • Bel makes milk low-methane, working across its entire Slovakian dairy chain with partner dsm-firmenich

    22 May 2023

    Bel makes milk low-methane, working across its entire Slovakian dairy chain with partner dsm-firmenich

  • dsm-firmenich Running Team makes global debut to pioneer a new era of elite running

    5 January 2026

    dsm-firmenich Running Team makes global debut to pioneer a new era of elite running

  • dsm-firmenich unveils the Cloud Dancer fragrance collection inspired by PANTONE® Color of the Year 2026

    4 December 2025

    dsm-firmenich unveils the Cloud Dancer fragrance collection inspired by PANTONE® Color of the Year 2026

  • dsm-firmenich launches The Art of Progress Prize

    25 November 2025

    dsm-firmenich launches The Art of Progress Prize

  • dsm-firmenich unveils emotiOn™ social connection

    2 September 2025

    dsm-firmenich unveils emotiOn™ social connection

  • dsm-firmenich announces Jonathan Simon as next President of Fine Fragrance

    1 July 2025

    dsm-firmenich announces Jonathan Simon as next President of Fine Fragrance

  • dsm-firmenich and the United Nations World Food Programme expand partnership through 2027

    25 June 2025

    dsm-firmenich and the United Nations World Food Programme expand partnership through 2027

  • dsm-firmenich and Honeywell have reached a settlement to resolve their disputes relating to dsm-firmenich’s US Patent No. 10,280,532 and Honeywell’s Spectra® MG BIO Blue fiber.

    13 June 2025

    dsm-firmenich and Honeywell have reached a settlement to resolve their disputes relating to dsm-firmenich’s US Patent No. 10,280,532 and Honeywell’s Spectra® MG BIO Blue fiber.

  • dsm-firmenich breaks ground on new state-of-the-art production facility for the development of flavors and functional blends in Parma, Italy

    4 June 2025

    dsm-firmenich breaks ground on new state-of-the-art production facility for the development of flavors and functional blends in Parma, Italy

  • On the rise: dsm-firmenich opens state-of-the-art Princeton Baking Innovation Center in Princeton, NJ

    20 May 2025

    On the rise: dsm-firmenich opens state-of-the-art Princeton Baking Innovation Center in Princeton, NJ

  • dsm-firmenich launches Maxiren®EVO: A revolutionary coagulant enzyme for enhanced cheese texture, taste, yield, and functionality

    20 March 2025

    dsm-firmenich launches Maxiren®EVO: A revolutionary coagulant enzyme for enhanced cheese texture, taste, yield, and functionality

  • dsm-firmenich scents the Swiss and Dutch Pavilions at Expo 2025 in Osaka

    17 March 2025

    dsm-firmenich scents the Swiss and Dutch Pavilions at Expo 2025 in Osaka

  • dsm-firmenich recognized as a "Top 100 Global Innovator" in LexisNexis 2025 Innovation Momentum Report

    21 February 2025

    dsm-firmenich recognized as a "Top 100 Global Innovator" in LexisNexis 2025 Innovation Momentum Report

  • dsm-firmenich Unveils Mocha Mousse, a New Sensual Scent Inspired by the PANTONE® Color of the Year 2025

    6 December 2024

    dsm-firmenich Unveils Mocha Mousse, a New Sensual Scent Inspired by the PANTONE® Color of the Year 2025

  • dsm-firmenich presents ‘Imagine: The Future of Fragrances in the Middle East’ at Beauty World 2024

    30 October 2024

    dsm-firmenich presents ‘Imagine: The Future of Fragrances in the Middle East’ at Beauty World 2024

  • dsm-firmenich participates in Beauty World Dubai 2024

    21 October 2024

    dsm-firmenich participates in Beauty World Dubai 2024

  • dsm-firmenich Welcomes Nicole Mancini as Fine Fragrance Principal Perfumer

    29 August 2024

    dsm-firmenich Welcomes Nicole Mancini as Fine Fragrance Principal Perfumer

  • dsm-firmenich to launch groundbreaking new sports nutrition solutions in collaboration with Team dsm-firmenich PostNL

    26 June 2024

    dsm-firmenich to launch groundbreaking new sports nutrition solutions in collaboration with Team dsm-firmenich PostNL

  • dsm-firmenich gains momentum showcasing the best in ingredients innovation and fragrance experience

    18 June 2024

    dsm-firmenich gains momentum showcasing the best in ingredients innovation and fragrance experience

  • dsm-firmenich dual head office Maastricht inaugurated by Queen Maxima of the Netherlands

    30 May 2024

    dsm-firmenich dual head office Maastricht inaugurated by Queen Maxima of the Netherlands

  • dsm-firmenich commits to a strategic partnership with The Colors

    29 May 2024

    dsm-firmenich commits to a strategic partnership with The Colors

  • dsm-firmenich presents Mind Nose + Matter™ 2024 - “Momentum”

    17 May 2024

    dsm-firmenich presents Mind Nose + Matter™ 2024 - “Momentum”

  • dsm-firmenich and Lallemand Health Solutions unite to launch synergistic synbiotic solutions

    8 May 2024

    dsm-firmenich and Lallemand Health Solutions unite to launch synergistic synbiotic solutions

  • dsm-firmenich Partners with ExoLab Italia to Pioneer Plant-Derived Exosome Technology in Personal Care Market

    16 April 2024

    dsm-firmenich Partners with ExoLab Italia to Pioneer Plant-Derived Exosome Technology in Personal Care Market

dsm-firmenich fait le point sur ses activités au troisième trimestre 2025

dsm-firmenich a annoncé sa mise à jour commerciale pour le troisième trimestre 2025 le 30 octobre 2025.

Nouvelles de nos entreprises

Parfumerie et beauté

Goût, texture et santé

Santé, nutrition et soins

Nutrition et santé animales

Pour en savoir plus sur les nouvelles, les publications et les derniers développements de l'activité Nutrition animale & Health, cliquez ici.

Nos dernières déclarations

Informations erronées sur Bovaer® 

Téléchargements de médias

Dans notre médiathèque, vous trouverez des images et des vidéos concernant notre comité exécutif, l'ouverture de notre nouveau siège à Maastricht et bien d'autres choses encore.

Rester informé

Soyez les premiers informés des principaux résultats financiers et de l'actualité de l'entreprise, alors que nous continuons à façonner l'avenir et à donner vie au progrès.

Archives des nouvelles

Le 9 mai 2023, DSM et Firmenich fusionnent et deviennent une seule et même entreprise. Vous pouvez accéder aux archives des publications de DSM & Firmenich avant leur fusion ici.

Contactez notre équipe média

Nous sommes là pour aider les professionnels des médias. Vous pouvez contacter notre équipe
En savoir plus
  • Our Company

    Discover how we bring progress to life through purpose-led science, sustainable solutions, building on our 150-year heritage, and leading by example.

  • Executive Committee

    The Executive Committee is organized and led by our CEO, who is responsible for overseeing the operational management of the Group.

  • Our businesses

    Four complementary businesses, all powered by purpose, people, and pioneering science. A winning formula across nutrition, health, and beauty.